U.S. Beverage Stock News

Nektar Therapeutics (NKTR) has launched the first two global Phase 3 ZENITH AD trials for rezpegaldesleukin in moderate to severe atopic dermatitis, supported by earlier Phase 2b data and FDA Fast Track designations. See our latest analysis for Nektar Therapeutics. The latest rezpegaldesleukin Phase 3 launch comes after a sharp shift in sentiment around Nektar Therapeutics, with a 1-year total shareholder return of 199.05% and a year to date share price return of 62.89%. However, momentum has...

Qiagen (QGEN) is back in focus after highlighting its molecular testing tools in the U.S. cyclosporiasis response and launching a CE-IVDR-certified bloodstream infection and antimicrobial resistance panel for its QIAstat-Dx platform in Europe. See our latest analysis for Qiagen. Qiagen’s recent focus on infectious disease diagnostics comes as the stock trades at US$41.37, with a 90 day share price return of 21.6% but a year to date share price return that is down 13.03%, and a 1 year total...

Gaming and Leisure Properties (GLPI) is back on investor radars after a recent move in its share price, with the stock closing at $45.17. That shift has renewed interest in its underlying real estate fundamentals. See our latest analysis for Gaming and Leisure Properties. Over the past year, Gaming and Leisure Properties has paired a 5.77% total shareholder return with relatively muted share price moves. The recent 1-day share price return of 1.69% contrasts with a 90-day share price return...

Commvault Systems (CVLT) is back in focus this week as the data protection software company prepares to report earnings before markets open on Tuesday, with investors watching a projected slowdown in revenue growth. See our latest analysis for Commvault Systems. At a share price of $142.31, Commvault Systems has posted a 45.24% 90 day share price return, yet the 1 year total shareholder return is down 12.92%. This indicates that recent momentum is improving compared with a weaker longer term...

Earlier this year, Unusual Machines, Inc. announced a collaboration with Lantronix Inc. to develop autonomous drone components that combine edge AI computing with flight control systems for the commercial drone market. This partnership could strengthen Unusual Machines’ position in higher-value drone technologies by pairing its hardware capabilities with Lantronix’s embedded computing and connectivity expertise. We’ll now examine how this edge AI and flight-control collaboration with...

HBT Financial (HBT) is back on investors’ radar after reporting second quarter earnings that topped analyst estimates, alongside a higher quarterly dividend and continued share repurchases. See our latest analysis for HBT Financial. That backdrop of better than expected earnings, a higher dividend and ongoing buybacks sits alongside firm recent share price momentum, with a 16.24% 3 month share price return, 29.48% year to date share price return and a 33.98% 1 year total shareholder...

Q2 earnings and buybacks put T-Mobile US (TMUS) under the spotlight T-Mobile US (TMUS) has drawn investor attention after reporting second quarter 2026 results alongside an update on its ongoing share repurchase program, combining fresh earnings data with a clearer view of capital returns. For the quarter ended June 30, 2026, the company reported revenue of US$22,791 million compared with US$21,132 million a year earlier, while net income was US$3,239 million versus US$3,222 million in the...

FTI Consulting (FCN) has drawn attention after appointing Dylan Ryan and Emmanuel Fages as Senior Managing Directors, moves that sharpen its focus on financial crime risk management and energy and utilities advisory work for global clients. See our latest analysis for FTI Consulting. FTI Consulting's latest executive hires arrive as the stock trades at $159.79, with a 1-day share price return of 1.49% and a 30-day share price return of 5.75%. This contrasts with a 1-year total shareholder...

With the Federal Reserve sitting on a knife edge between holding rates and a possible 25 basis point hike, interest rate expectations, bond yields, and renewed Middle East tensions are back in the spotlight for banking and financial stocks. Higher oil prices and mixed inflation signals are feeding fresh volatility into funding costs and loan demand, while two year Treasury yields around 4% keep rate hike odds alive. This article looks at three large, financially healthy stocks from our...

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, although it has risen by 15% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this context, identifying stocks that are trading below their estimated worth can offer potential investment opportunities for those seeking value amidst fluctuating market conditions.

The United States market has shown resilience with a 15% increase over the past year, despite a recent 1.0% dip in the last week, and earnings are projected to grow by 17% annually in the coming years. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often indicate confidence from those closest to the business operations and strategy.

Over the last 7 days, the U.S. market has dropped 1.0%, but it remains up 15% over the past year with earnings forecast to grow by 17% annually. In light of these conditions, identifying stocks with strong financial health and growth potential becomes crucial for investors seeking opportunities beyond traditional investments. Penny stocks, though a somewhat outdated term, still represent a relevant investment area where smaller or newer companies can offer significant returns when backed by...

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, although it has seen an impressive rise of 15% over the past year, with earnings projected to grow by 17% annually. In this context, selecting dividend stocks like Eagle Financial Services can be a strategic choice for investors seeking stable income and potential growth amidst fluctuating market conditions.

Rising concerns about U.S. government debt and interest rate risk are pushing many investors to rethink how they use bonds, especially long-term Treasuries. With Jamie Dimon openly cautioning against locking into long maturities, attention is shifting toward short-term bond products and the companies that issue or distribute them. Some stocks could benefit from stronger flows into ultra short-term bond ETFs, while others tied more closely to long-duration products may face tougher questions...

How VeriSign’s latest earnings, guidance and capital returns set the stage VeriSign (VRSN) is back in focus after releasing second quarter 2026 results, updating full year guidance, affirming its dividend and lifting its share repurchase authorization. This gives investors several fresh data points to assess. See our latest analysis for VeriSign. The earnings beat, higher 2026 guidance, affirmed dividend and larger buyback authorization have coincided with a 7.04% 1 day share price return and...

Barington Capital has escalated its campaign at Chemed (CHE), pressing the board to launch a strategic review, cut executive perks, and refresh governance. These moves put fresh attention on how the company allocates capital. See our latest analysis for Chemed. Chemed’s share price has moved to US$511.13, with a 1 month share price return of 10.33% and a 3 month share price return of 21.38%. The 1 year total shareholder return of 10.26% contrasts with a slightly negative 3 year total...

Alpha Tau Medical (NasdaqCM:DRTS) is back in focus after reporting clinical data showing a 100% objective response rate for its Alpha DaRT plus pembrolizumab regimen in elderly head and neck cancer patients, presented at a major specialist conference. See our latest analysis for Alpha Tau Medical. Despite the sharp one day share price pullback of about 5.6% to US$12.50, Alpha Tau Medical still shows strong momentum, with a 30 day share price return of about 14.9% and a year to date share...

How Vipshop Holdings Stock Has Been Trading Recently Vipshop Holdings (VIPS) has seen mixed share performance recently, with the stock down over the past year even as the price gained over the past month and the past 3 months. See our latest analysis for Vipshop Holdings. At a share price of $14.25, Vipshop Holdings reflects mixed momentum, with a 30 day share price return of 8.45% contrasting with a year to date decline of 19.54% and a 1 year total shareholder return that is down 5.23%. This...

Earlier in July 2026, Fermi Inc. appointed Rob Masson as CFO and named George Wentz, Anna Bofa, and Jacobo Ortiz to key officer roles, while director Miles Everson resigned after raising concerns about board governance and access to meeting minutes. The unusual combination of fresh senior leadership appointments and a public director departure over transparency issues raises important questions about how Fermi balances rapid growth ambitions with board oversight. Now we'll consider how the...

Healthcare investors are watching AstraZeneca closely after fresh comments about operating at Chinese speed, reaffirming a 2030 sales goal of $80b and reporting 6% revenue growth at constant exchange rates in the first half of 2026, even as the Wainua trial setback put its pipeline under scrutiny. This mix of confidence, competition from China and pressure to accelerate drug development could reshape how large pharmaceutical and biotechnology stocks are viewed. This article walks through 3...

How Arlo Technologies Stock Has Been Trading Around Recent Performance Figures Arlo Technologies (ARLO) has been drawing attention after recent performance metrics highlighted mixed returns over different periods, prompting investors to reassess how the stock’s current pricing lines up with its fundamentals. See our latest analysis for Arlo Technologies. At a share price of $12.87, Arlo Technologies has seen a 1-day share price return of 2.71%, while its year to date share price return is...

Recently, Ternium has drawn fresh investor attention as analysts highlight a gap between its current valuation and its reported financial results, while the company continues heavy investment in its Pesqueria Industrial Center to expand steelmaking capacity. An interesting angle is how these capacity additions are being closely linked to potential long-term demand tied to nearshoring trends and infrastructure projects, which some investors see as a key support for the company’s operational...

Gibraltar Industries has completed the sale of its Renewables business, exiting solar operations to concentrate its resources on the Residential, Agtech, and Infrastructure segments. This move simplifies the company’s portfolio but heightens its dependence on these core end markets, sharpening both execution risk and capital allocation decisions. Next, we’ll examine how Gibraltar’s exit from Renewables and renewed focus on core businesses may reshape its broader investment narrative. The...

Popular (BPOP) just delivered a packed update for investors, combining higher second quarter earnings, a raised full year net interest income outlook, a larger dividend, and a fresh share repurchase authorization. See our latest analysis for Popular. At a share price of $171.73, Popular has seen momentum build recently, with a 90 day share price return of 13.92% and a 1 year total shareholder return of 52.42% reinforcing a much stronger 3 and 5 year record. If Popular’s strong recent run has...